Second Circular and Call For Participation for IMV 2005

The Second International Conference on

Immunopotentiators in Modern Vaccines
IMV 2005 – 18-20 May 2005, Torrequebrada Hotel, Malaga, Spain

Conference Chairman:
Virgil Schijns (Intervet BV, The Netherlands)

Jan Holmgren (University of Gothenberg, Sweden)
Derek O’Hagan (Chiron, Emeryville, USA)
Philippe Moingeon (Stallergenes SA, Antony, France)
Filippo Belardelli ( ISS, Rome, Italy)
Luke O’Neill (Trinity College Dublin, Ireland)
Gwyn Davies (OM Pharma, Meyrin/Geneva, Switzerland)
Martin Bachmann (Cytos Biotechnology, Zurich, Switzerland)
Brian Ledwith (MERCK, West Point, USA)
Thea Sesardic (NIBSC, Potters Bar, UK)
Martin Pearse (CSL Limited, Australia)

IMV 2005 is the follow-up to the successful IMV 2002 meeting held in Prague, Czech Republic. The strong indications from IMV 2002 were that a regular update on the developments/issues surrounding ‘immunopotentiators for modern vaccines’ is a vital aspect of the growth of this important area of vaccinology.

IMV 2005 will once again offer an international forum to review the current state of research and developments/applications of immunopotentiators/adjuvants for modern vaccines and associated vaccine programmes/strategies.

IMV 2005 will be of interest to researchers involved in determining the mechanisms of adjuvant function and responses and optimising these responses, manufacturers of biologicals, those involved in the manufacture/licensing of injectable biologicals, and those interested in the control of infectious and non/infectious diseases.

Closing date for poster abstract submissions Friday 22nd April 2005